U.S. Funds Vaccine; U.K. Signs Antibody Test Deal: Virus Update

Global coronavirus cases topped 5 million, doubling in the past month, and infections rose at a record pace in Brazil and Indonesia. AstraZeneca received $1.2 billion in U.S. funding to develop a vaccine, while CanSino Biologics signed a deal to test and sell a Canadian vaccine candidate.